India has improved its position by seven places to rank at 83rd place among 111 countries in the latest Henley Passport Index, released for Q1 of 2022.
The drug regulator has granted Serum Institute of India's Covishield and Bharat Biotech's Covaxin Covid-19 vaccines "conditional market authorisation".
After the recommendation by the three-member committee, the Centre has decided to continue with the existing annual income limit of Rs 8 lakh for the identification of the economically weaker sections (EWS).
EXAMIANS